DENTSPLY SIRONA(XRAY)
Search documents
Dentsply Sirona Announces Retirement of Eric K. Brandt from the Board of Directors
Newsfilter· 2024-02-29 11:30
CHARLOTTE, N.C., Feb. 29, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced that Eric K. Brandt, who has served as a Director on the Company's Board of Directors (the "Board") for nearly twenty years and as Chairman of the Board for six years, has informed the Board of his intention to retire at the May 2024 annual meeting and that he will not be standing for re-election. Mr. Brandt commented, "As I think back on the past two decades and all of ...
Dentsply Sirona Reports Fourth Quarter and Full Year 2023 Results, Provides Full Year 2024 Outlook, Raises Dividend
Newsfilter· 2024-02-29 11:00
FY23 net sales of $3,965 million increased 1.1%, organic sales increased 2.2%FY23 GAAP net income (loss) of ($132) million or ($0.62) per share, adjusted EPS of $1.83Q4 net sales of $1,012 million increased 2.9%, organic sales increased 1.9%Q4 GAAP net income of $67 million or $0.32 per share, adjusted EPS of $0.44FY24 outlook: organic sales flat to up 1.5%; adjusted EPS of $2.00 to $2.10 CHARLOTTE, N.C., Feb. 29, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XR ...
DENTSPLY SIRONA(XRAY) - 2023 Q4 - Annual Report
2024-02-28 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 0-16211 DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No. ...
What's in Store for DENTSPLY SIRONA (XRAY) in Q4 Earnings?
Zacks Investment Research· 2024-02-26 17:41
DENTSPLY SIRONA Inc. (XRAY) is scheduled to release fourth-quarter 2023 results on Feb 29, before the opening bell.In the last reported quarter, the company’s earnings beat estimates by 2.08%. It delivered an average earnings surprise of 20.65% in the past four quarters. Q4 EstimatesThe Zacks Consensus Estimate for revenues is pegged at $966.8 million. The consensus mark for earnings is pinned at 43 cents per share.Factors to NoteDENTSPLY SIRONA’s Technologies & Equipment segment is likely to have witnesse ...
Will Dentsply (XRAY) Beat Estimates Again in Its Next Earnings Report?
Zacks Investment Research· 2024-02-07 18:11
If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Dentsply International (XRAY) . This company, which is in the Zacks Medical - Dental Supplies industry, shows potential for another earnings beat.When looking at the last two reports, this dental products manufacturer has recorded a strong streak of surpassing earnings estimates. The company has topped estimates by 10.34%, on ...
Dentsply Sirona to Host Fourth Quarter and Full Year 2023 Conference Call on February 29th
Newsfilter· 2024-01-29 21:15
CHARLOTTE, N.C., Jan. 29, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced that the Company will be hosting an investor conference call and live webcast on Thursday, February 29, 2024, at 8:30 am ET to review its fourth quarter and full year 2023 financial results. A presentation related to the call will be available on the Investors section of the Company's website at https://investor.dentsplysirona.com. Conference Call / Webcast Information ...
Dentsply Sirona to Present at J.P. Morgan Healthcare Conference, Provides Update on Anticipated Full Year 2023 Results
Newsfilter· 2024-01-09 13:30
CHARLOTTE, N.C., Jan. 09, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) will present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024, at 7:30 am PT (10:30 am ET). As part of the conference, the Company is providing an update on its 2023 full year anticipated financial results, with net sales expected to be at or above the high end of the Company's previously provided outlook range of $3.90 billion to $3.94 billion. For th ...
DENTSPLY SIRONA(XRAY) - 2023 Q3 - Earnings Call Presentation
2023-11-02 19:36
Third Quarter 2023 Earnings Conference Call Dentsply Sirona November 2, 2023 Forward-Looking Statements and Associated Risks This presentation contains statements that do not directly and exclusively relate to historical facts which constitute forward-looking statements, including, statements and projections concerning, among other things, the expected timing, benefits and costs associated with the Company's restructuring plan described in this presentation. The Company's forward-looking statements represen ...
DENTSPLY SIRONA(XRAY) - 2023 Q3 - Earnings Call Transcript
2023-11-02 16:54
DENTSPLY SIRONA, Inc. (NASDAQ:XRAY) Q3 2023 Earnings Conference Call November 2, 2023 8:30 AM ET Company Participants Andrea Daley - VP, IR Simon Campion - CEO, President & Director Glenn Coleman - EVP & CFO Conference Call Participants Elizabeth Anderson - Evercore ISI Kevin Caliendo - UBS Jason Bednar - Piper Sandler & Co. Jeffrey Johnson - Robert W. Baird & Co. Jonathan Block - Stifel, Nicolaus & Company Operator Good day, and thank you for standing by. Welcome to the Dentsply Sirona Third Quarter 2023 E ...
DENTSPLY SIRONA(XRAY) - 2023 Q3 - Quarterly Report
2023-11-01 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-16211 DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 39-1434669 13320 Ballantyne Corporate Place, Char ...